8/25/2025 12:00:19 PM Most Favored Nation Drug Pricing Developments By Jeffrey Low Jed Smith Katherine Norris Stephanie Lewko +1 more... Show less On July 31, 2025, the White House released a fact sheet[1] discussing additional steps taken by the Trump administration surrounding...
5/23/2025 7:12:03 PM Most-Favored-Nation, Executive Order 14297|Forward Looking Perspectives for Drug Manufacturers, Pharmacy Benefit Managers, Health Plans, and Pharmacies By Jeffrey Low Jed Smith Katherine Norris On May 12, 2025, U.S. President Donald Trump signed an executive order (EO) titled “Delivering Most-Favored-Nation Prescription Drug...
2/13/2025 8:43:13 PM CMS Announces Selected Drugs for 2027 Maximum Fair Price Negotiations; New Administration Issues Executive Order Affecting the IRA – Then Clarifies By Katherine Norris Stephanie Lewko Jed Smith Scott Carr +1 more... Show less The Centers for Medicare and Medicaid Services (CMS) recently announced the second cohort of Medicare Part D drugs selected for Maximum...
11/6/2024 1:55:30 PM OCR’s 50th Right of Access Penalty By Ankura Consulting Introduction On October 17, 2024, the Office for Civil Rights (OCR) announced a civil monetary penalty against a Maryland-based dental...
10/7/2024 3:21:38 PM Quarterly Healthcare Transactions Review: Unveiling the Latest Industry Mergers and Acquisitions [Q2 2024] By Anthony Metke Robert Mundy Vin Phan Ankura is pleased to present an overview of healthcare services transactions announced or closed during Q2 2024 in the United States....
6/7/2024 1:54:45 PM Are You Paying Attention to Prior Authorization? Your Regulators Are. By Jeffrey Low Dorothy DeAngelis Kelli Howe Angela Sabbe +1 more... Show less With recent CMS mandates and state-level reforms, the healthcare industry faces a pivotal moment to improve prior authorization...
5/14/2024 5:54:41 PM Quarterly Healthcare Transactions Review: Unveiling the Latest Industry Mergers and Acquisitions [Q1 2024] By Anthony Metke Robert Mundy Ankura is pleased to present an overview of healthcare transactions announced or closed during Q1 2024 in the United States. Total...
4/2/2024 1:00:24 PM Four Lessons for Health Systems From the Private Equity Playbook (Video) By Mark Furgeson Robert Mundy Erin Nelson Watch the conversation between Ankura Healthcare Real Estate experts Mark Furgeson, Robert Mundy, and Erin Nelson as they discuss...
3/11/2024 1:00:21 PM The Focus of Federal Proposals on Pharmacy Benefit Management – 118th Congress By Jeffrey Low Featured Excerpt Over the past several years, legislators nationwide have scrutinized Pharmacy Benefit Managers (PBMs) due to various...
2/15/2024 5:02:31 PM HHS Imposes $4.75 Million Civil Monetary Penalty from Malicious Insider Cybersecurity Investigation By Ankura Consulting On February 6, 2024, the Health and Human Services (HHS), Office of Civil Rights (OCR) announced a settlement with Montefiore Medical...
2/8/2024 2:30:52 PM Quarterly Healthcare Transactions Review: Unveiling the Latest Industry Mergers and Acquisitions [February 2024] By Robert Mundy Anthony Metke Ankura is pleased to present an overview of healthcare transactions announced or closed during Q4 2023 in the United States. Total...
11/1/2023 5:21:52 PM Four Lessons for Health Systems From the Private Equity Playbook By Mark Furgeson Robert Mundy The value of private equity (PE) deals in the healthcare sector has grown from <$2B in 2001 to $151 billion in deals in 2021.1 Barring...